Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Methylphenidate for Hyperactivity and Impulsiveness in Children and Adolescents With Pervasive Developmental Disorders

NCT00025779 is registered in ClinicalTrials.gov with National Institute of Mental Health (NIMH) as lead sponsor.

NCT NCT00025779
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00025779 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Methylphenidate for Hyperactivity and Impulsiveness in Children and Adolescents With Pervasive Developmental Disorders
Lead sponsor
National Institute of Mental Health (NIMH)
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2001
Completion date
Not reported
Enrollment
60
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficit disorder with hyperactivity, autistic disorder, pervasive development disorders